US2020362339A1PendingUtilityA1

Processes for preparing phosphorodiamidate morpholino oligomers via fast-flow synthesis

Assignee: SAREPTA THERAPEUTICS INCPriority: Sep 25, 2017Filed: Sep 25, 2018Published: Nov 19, 2020
Est. expirySep 25, 2037(~11.2 yrs left)· nominal 20-yr term from priority
C08G 79/02C12N 2310/3233C07F 9/65583C07F 9/65616C12N 2310/11C12N 2330/30C12N 2310/314C12N 15/113
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are processes for preparing an oligomer (e.g., a morpholino oligomer). The synthetic processes described herein may be advantageous to scaling up oligomer synthesis while maintaining overall yield and purity of a synthesized oligomer.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A process for preparing an oligomeric compound of Formula (I): 
       
         
           
           
               
               
           
         
         wherein
 n is an integer from 9 to 39; 
 T is OH or 
 
       
       
         
           
           
               
               
           
         
         
            and 
           each R 2  is, independently for each occurrence, selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
       
       wherein the process comprises the sequential steps of: 
       (a) contacting a compound of Formula (A1): 
       
         
           
           
               
               
           
         
         wherein
 B is 
 
       
       
         
           
           
               
               
           
         
         
           R 1  is a support-medium; and 
           R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; 
         
       
       with a deblocking agent to form the compound of Formula (II): 
       
         
           
           
               
               
           
         
         wherein B is 
       
       
         
           
           
               
               
           
         
          and
 R 1  is a support-medium; 
 
       
       (b) contacting the compound of Formula (II) with a compound of Formula (A2): 
       
         
           
           
               
               
           
         
         wherein R 5  is 
       
       
         
           
           
               
               
           
         
         
           R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
           R 4  is selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       to form a compound of Formula (A3): 
       
         
           
           
               
               
           
         
         wherein
 B is 
 
       
       
         
           
           
               
               
           
         
         
           R 1  is a support-medium; 
           R 5  is 
         
       
       
         
           
           
               
               
           
         
         
           R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
           R 4  is selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       (c) contacting the compound of Formula (A3) with a deblocking agent to form a compound of Formula (IV):
 wherein B is 
 
       
         
           
           
               
               
           
         
       
       
         
           
           
               
               
           
         
         
           R 1  is a support-medium; 
           R 6  is 
         
       
       
         
           
           
               
               
           
         
         
            and 
           R 4  is selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       (d) contacting the compound of Formula (IV) with a compound of Formula (A4): 
       
         
           
           
               
               
           
         
       
       in the presence of a lewis acid catalyst;
 wherein
 R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
 R 4  is selected from the group consisting of: 
 
 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       to form a compound of Formula (A5): 
       
         
           
           
               
               
           
         
         wherein R 7  is of Formula (A5a) or Formula (A5b): 
       
       
         
           
           
               
               
           
         
         
           B is 
         
       
       
         
           
           
               
               
           
         
         
           R 1  is a support-medium; 
           R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
           R 4  is selected from: 
         
       
       
         
           
           
               
               
           
         
       
       (e) performing Y iterations of the sequential steps of:
 (e1) contacting the product formed by the immediately prior step with a deblocking agent; and 
 (e2) contacting the compound formed by the immediately prior step with a compound of Formula (A8): 
 
       
         
           
           
               
               
           
         
         in the presence of a lewis acid catalyst;
 wherein
 Y is n−1 if R 7  is of the Formula (A5a) or Y is n−2 if R 7  is of the Formula (A5b); 
 R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
 R 4  is, independently for each compound of Formula (A8), selected from the group consisting of: 
 
 
       
       
         
           
           
               
               
           
         
         to form a compound of Formula (A9): 
       
       
         
           
           
               
               
           
         
         
           (A9); 
         
         wherein R 8  is 
       
       
         
           
           
               
               
           
         
         
           B is 
         
       
       
         
           
           
               
               
           
         
         
           n is an integer from 9 to 39; 
           R 1  is a support-medium; 
           R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
           R 4  is, independently for each occurrence, selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
            and 
         
       
       (f) contacting the compound of Formula (A9) with a deblocking agent to form a compound of Formula (A10): 
       
         
           
           
               
               
           
         
         wherein R 9  is 
       
       
         
           
           
               
               
           
         
         
           B is 
         
       
       
         
           
           
               
               
           
         
         
           n is an integer from 9 to 39; 
           R 1  is a support-medium; and 
           R 4  is, independently for each occurrence, selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
       
       (g) contacting the compound of Formula (A10) with a cleaving agent to form a compound of Formula (A11): 
       
         
           
           
               
               
           
         
         wherein
 R 9  is 
 
       
       
         
           
           
               
               
           
         
         
           
             C is 
           
         
       
       
         
           
           
               
               
           
         
         
           
              or H; 
             n is an integer from 9 to 39; and 
             R 4  is, independently for each occurrence, selected from the group consisting of: 
           
         
       
       
         
           
           
               
               
           
         
         
           
              and 
           
         
       
       (h) contacting the compound of Formula (A11) with a deprotecting agent to form the oligomeric compound of Formula (I). 
     
     
         2 . The process of  claim 1 , wherein one of steps (d) or (e2) further comprises contacting the compound formed by the immediately prior step with a capping agent. 
     
     
         3 . The process of  claim 1 , wherein steps (a), (c), (e1), and (f) further comprise contacting the deblocked compound of each step with a neutralization agent. 
     
     
         4 . The process of  claim 1 , wherein the compounds of Formula (A4) and Formula (A8) are each, independently, in a solution comprising N-ethylmorpholine and dimethylimidazolidinone. 
     
     
         5 . The process of  claim 1 , wherein the cleavage agent comprises dithiothreitol and 1,8-diazabicyclo[5.4.0]undec-7-ene. 
     
     
         6 . The process of  claim 1 , wherein for steps (a)-(g), B is 
       
         
           
           
               
               
           
         
       
       and for step (h), C is 
       
         
           
           
               
               
           
         
       
     
     
         7 . The process according to  claim 1 , wherein any of steps (a), (b), (c), (d), (e1), (e2), (f), (g), or (h) are carried out in a batchwise synthesis or in a continuous synthesis. 
     
     
         8 . A continuous process for preparing an oligomeric compound of Formula (A11): 
       
         
           
           
               
               
           
         
         wherein R 9  is 
       
       
         
           
           
               
               
           
         
         
           C is 
         
       
       
         
           
           
               
               
           
         
         
           n is an integer from 9 to 39; and 
           R 4  is, independently for each occurrence, selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       wherein the process comprises the sequential steps of: 
       (a) contacting a deblocking agent with a compound of Formula (A3): 
       
         
           
           
               
               
           
         
         wherein B is 
       
       
         
           
           
               
               
           
         
         
           R 1  is a support-medium; 
           R 5  is 
         
       
       
         
           
           
               
               
           
         
         
            and 
           R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; 
         
       
       in a reactor vessel to form a compound of Formula (IV): 
       
         
           
           
               
               
           
         
         wherein B is 
       
       
         
           
           
               
               
           
         
         
           R 1  is a support-medium; 
           R 6  is 
         
       
       
         
           
           
               
               
           
         
       
       (b) washing the compound of Formula (IV) with a washing solvent and a neutralizing agent, wherein the washing comprises passing a washing solvent and a neutralizing agent through the reactor vessel; 
       (c) washing the compound of Formula (IV) with a washing solvent, wherein the washing comprises passing a washing solvent through the reactor vessel; 
       (d) washing the compound of Formula (IV) with a coupling solvent, wherein the washing comprises passing a coupling solvent through the reactor vessel; 
       (e) introducing to the reactor vessel a lewis acid and a compound of Formula (A4): 
       
         
           
           
               
               
           
         
         wherein
 R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
 R 4  is selected from the group consisting of: 
 
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       such that the compound of formula (A4) contacts the compound of Formula (IV) to form a compound of Formula (A5): 
       
         
           
           
               
               
           
         
         wherein R 7  is of the Formula (A5a) or Formula (A5b): 
       
       
         
           
           
               
               
           
         
         
           B is 
         
       
       
         
           
           
               
               
           
         
         
           R 1  is a support-medium; 
           R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
           R 4  is selected from: 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       (f) washing the compound of Formula (A5) with a coupling solvent, wherein the washing comprises passing a coupling solvent through the reactor vessel; 
       (g) performing Y iterations of the sequential steps of:
 (g1) washing the product formed by the immediately prior step with a washing solvent, wherein the washing comprises passing a washing solvent through the reactor vessel; 
 (g2) introducing a deblocking agent into the reactor vessel such that it contacts the product formed by the immediately prior step; 
 (g3) washing the product formed by the immediately prior step with a washing solvent and a neutralizing agent, wherein the washing comprises passing a washing solvent and a neutralizing agent through the reactor vessel; 
 (g4) washing the product formed by the immediately prior step with a washing solvent, wherein the washing comprises passing a washing solvent through the reactor vessel; 
 (g5) washing the product formed by the immediately prior step with a coupling solvent, wherein the washing comprises passing a coupling solvent through the reactor vessel; 
 (g6) introducing to the reactor vessel containing the product formed by the immediately prior step a lewis acid and a compound of Formula (A8): 
 
       
         
           
           
               
               
           
         
         
           wherein
 Y is n−1; 
 R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
 R 4  is, independently for each compound of Formula (A8), selected from the group consisting of: 
 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         such that the compound of Formula (A8) contacts the compound formed by the immediately prior step to form a compound of Formula (A9): 
       
       
         
           
           
               
               
           
         
         
           wherein R 8  is 
         
       
       
         
           
           
               
               
           
         
         
           
             B is 
           
         
       
       
         
           
           
               
               
           
         
         
           
             n is an integer from 9 to 39; 
             R 1  is a support-medium; 
             R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
             R 4  is, independently for each occurrence, selected from the group consisting of: 
           
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       (h) washing the compound of Formula (A9) with a coupling solvent to remove the compound of Formula (A8), wherein the washing comprises passing a coupling solvent through the reactor vessel; 
       (i) washing the compound of Formula (A9) with a washing solvent to remove the coupling solvent, wherein the washing comprises passing a washing solvent through the reactor vessel; 
       (j) contacting a deblocking agent with a compound of Formula (A9) in a reactor vessel to form a compound of Formula (A10): 
       
         
           
           
               
               
           
         
         wherein R 9  is 
       
       
         
           
           
               
               
           
         
         
           B is 
         
       
       
         
           
           
               
               
           
         
         
           n is an integer from 9 to 39; 
           R 1  is a support-medium; and 
           R 4  is, independently for each occurrence, selected from the group consisting of: 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
            and 
         
       
       (k) contacting a cleaving agent with a compound of Formula (10) in a reactor vessel to form a compound of Formula (A11). 
     
     
         9 . The process of  claim 8 , wherein steps (a), (g2), and (j) further comprise contacting the deblocked compound of each respective step with a neutralization agent. 
     
     
         10 . The process of  claim 8 , wherein the washing solvent is a halogenated solvent. 
     
     
         11 . The process of  claim 8 , wherein the coupling solvent is 1,3-dimethyl-2-imidazolidinone or N-methyl-2-pyrrolidone. 
     
     
         12 . The process of  claim 8 , wherein for steps (a)-(j), B is 
       
         
           
           
               
               
           
         
       
       and for step (k), C is 
       
         
           
           
               
               
           
         
       
     
     
         13 . The process of  claim 8 , wherein any of steps (a), (b), (c), (d), (e), (f), (g1), (g2), (g3), (g4), (g5), (g6), (h), (i), (j), and (k) are optionally carried out in a batchwise process. 
     
     
         14 . The process of  claim 8 , wherein the process is performed in a flow-through reactor, the flow-through reactor comprising at least:
 (a) a feeding zone, wherein the feeding zone comprises one or more feed lines each equipped with a pump, and wherein the inlet zones of the feed lines are independently connected to vessels comprising a neutralizing agent, coupling solvent, a deblocking agent, washing solvent, and a compound of Formula (A8):   
       
         
           
           
               
               
           
         
         
           wherein
 R 3  is selected from the group consisting of trityl, monomethoxytrityl, dimethoxytrityl and trimethoxytrityl; and 
 R 4  is, independently for each compound of Formula (A8), selected from the group consisting of: 
 
         
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       wherein the compound of Formula (A8) is dissolved in a coupling solvent;
 (b) a reaction zone that is connected to the outlet zone of the one or more feed lines and which contains a PMO synthesis resin; 
 (c) an outlet zone, whereby waste stream or product can be independently collected; 
 (d) a pressure control device; and 
 (e) a means of independently controlling the temperature of the feeding zone and the reaction zone. 
 
     
     
         15 . The process of  claim 14 , wherein the flow-through reactor is used for the preparation of Eteplirsen. 
     
     
         16 . The process of  claim 1 , wherein the deblocking agent is selected from the group consisting of chloroacetic acid, dichloroacetic acid, trichloroacetic acid, fluoroacetic acid, difluoroacetic acid, and trifluoroacetic acid. 
     
     
         17 . The process of  claim 1 , wherein the deblocking agent used in each step is a solution comprising a halogenated acid. 
     
     
         18 . The process of  claim 1 , wherein the Lewis acid is selected from a group consisting of LiCl, LiBr, LiI, and LiOTf. 
     
     
         19 . The process of  claim 1 , wherein the neutralization agent is in a solution comprising a halogenated solvent and isopropyl alcohol. 
     
     
         20 . The process of  claim 1 , wherein the neutralization agent is a monoalkyl, dialkyl, or trialkyl amine.

Join the waitlist — get patent alerts

Track US2020362339A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.